title: Mutation and evolutionary analyses identify NR2E1-candidate-regulatory mutations in humans with severe cortical malformations.
abstract: Nuclear receptor 2E1 (NR2E1) is expressed in human fetal and adult brains; however, its role in human brain-behavior development is unknown. Previously, we have corrected the cortical hypoplasia and behavioral abnormalities in Nr2e1(-/-) mice using a genomic clone spanning human NR2E1, which bolsters the hypothesis that NR2E1 may similarly play a role in human cortical and behavioral development. To test the hypothesis that humans with abnormal brain-behavior development may have null or hypomorphic NR2E1 mutations, we undertook the first candidate mutation screen of NR2E1 by sequencing its entire coding region, untranslated, splice site, proximal promoter and evolutionarily conserved non-coding regions in 56 unrelated patients with cortical disorders, namely microcephaly. We then genotyped the candidate mutations in 325 unrelated control subjects and 15 relatives. We did not detect any coding region changes in NR2E1; however, we identified seven novel candidate regulatory mutations that were absent from control subjects. We used in silico tools to predict the effects of these candidate mutations on neural transcription factor binding sites (TFBS). Four candidate mutations were predicted to alter TFBS. To facilitate the present and future studies of NR2E1, we also elucidated its molecular evolution, genetic diversity, haplotype structure and linkage disequilibrium by sequencing an additional 94 unaffected humans representing Africa, the Americas, Asia, Europe, the Middle East and Oceania, as well as great apes and monkeys. We detected strong purifying selection, low genetic diversity, 21 novel polymorphisms and five common haplotypes at NR2E1. We conclude that protein-coding changes in NR2E1 do not contribute to cortical and behavioral abnormalities in the patients examined here, but that regulatory mutations may play a role.
authors.affiliation: Centre for Molecular Medicine and Therapeutics and Child & Family Research Institute, Vancouver, Canada.
authors.forename: R A
authors.initials: RA
authors.lastname: Kumar
authors.forename: S
authors.initials: S
authors.lastname: Leach
authors.forename: R
authors.initials: R
authors.lastname: Bonaguro
authors.forename: J
authors.initials: J
authors.lastname: Chen
authors.forename: D W
authors.initials: DW
authors.lastname: Yokom
authors.forename: B S
authors.initials: BS
authors.lastname: Abrahams
authors.forename: L
authors.initials: L
authors.lastname: Seaver
authors.forename: C E
authors.initials: CE
authors.lastname: Schwartz
authors.forename: W
authors.initials: W
authors.lastname: Dobyns
authors.forename: A
authors.initials: A
authors.lastname: Brooks-Wilson
authors.forename: E M
authors.initials: EM
authors.lastname: Simpson
mesh_terms: D000818:Animals; D016022:Case-Control Studies; D002540:Cerebral Cortex / Q000002:abnormalities / Q000378:metabolism*; D005006:Ethnicity / Q000235:genetics; D019143:Evolution, Molecular; D005260:Female; D005820:Genetic Testing; D006239:Haplotypes; D006801:Humans; D008607:Intellectual Disability / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D008297:Male; D016555:Matched-Pair Analysis; D008831:Microcephaly / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D057093:Orphan Nuclear Receptors; D010375:Pedigree; D011323:Primates / Q000235:genetics; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics* / Q000378:metabolism; D012016:Reference Values; D050436:Regulatory Elements, Transcriptional / Q000235:genetics*
chemical_list: C088601:NR2E1 protein, human; D057093:Orphan Nuclear Receptors; D018160:Receptors, Cytoplasmic and Nuclear